Progression independent of relapse activity (PIRA) in relapsing-remitting multiple sclerosis patients on first-line immunomodulatory treatment with fingolimod vs. platform injectables

被引：0
|
作者：
von Wyl, V. [1 ]
Benkert, P. [2 ]
Lorscheider, J. [3 ,4 ]
Hanni, P. [5 ]
Lienert, C. [6 ]
Decard, B. [3 ,4 ]
Kuhle, J. [3 ,4 ]
Derfuss, T. [3 ,4 ]
Kappos, L. [3 ,4 ]
Yaldizli, O. [3 ,4 ]
机构：
[1] Univ Zurich, Dept Epidemiol Biostat & Prevent, Zurich, Switzerland
[2] Univ Hosp Basel, Dept Clin Res, Clin Trial Unit, Basel, Switzerland
[3] Univ Hosp Basel, Dept Med, Neurol Clin & Policlin, Basel, Switzerland
[4] Univ Basel, Basel, Switzerland
[5] Swiss Assoc Joint Tasks Hlth Insurers, Solothurn, Switzerland
[6] Rheinburg Clin, Dept Neurol, Walzenhausen, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P751
引用
收藏
页码：381 / 382
页数：2
相关论文
共 50 条
  • [41] Baseline serum glial fibrillary acidic protein levels associate with progression independent of relapse activity in relapsing-remitting multiple sclerosis
    Rosenstein, Igal
    Axelsson, Markus
    Malmestrom, Clas
    Sandgren, Sofia
    Lycke, Jan
    Novakova, Lenka
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 575 - 576
  • [42] Treatment patterns in relapsing-remitting multiple sclerosis patients starting injectable versus oral first-line drug modifying therapies
    Coutinho, M.
    Faustino, P.
    Leitao, L.
    Capela, C.
    Brum, M.
    Parra, J.
    Sequeira, J.
    Barros, A.
    Araujo, C.
    Sousa, A.
    Ladeira, F.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 559 - 559
  • [43] The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis
    Datt, Joe
    Baldock, Laura
    Pull, Emily
    Webber, Bryn
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 5 : 40 - 46
  • [44] Predictors of Response to First-Line Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis
    Castillo-Trivino, Tamara
    Gajofatto, Alberto
    Bacchetti, Peter
    Waubant, Emmanuelle
    NEUROLOGY, 2010, 74 (09) : A155 - A155
  • [45] The relationship between smoking and disease activity in patients with relapsing-remitting multiple sclerosis on immunomodulatory therapy
    Rakoca, Michal
    Tywoniuk, Anna
    Adamczyk-Sowa, Monika
    Kulakowska, Alina
    Koziarska, Dorota
    Kubicka-Baczyk, Katarzyna
    Jakubowicz-Lachowska, Dominika
    Wawrzyniak, Slawomir
    AKTUALNOSCI NEUROLOGICZNE, 2020, 20 (01): : 9 - 13
  • [46] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [47] Cytokine profile in relapsing-remitting multiple sclerosis patients and the association with the progression and the activity of the disease
    Kallaur, Ana Paula
    Oliveira, Sayonara Rangel
    Colado Simao, Andrea Name
    Delicato de Almeida, Elaine Regina
    Morimoto, Helena Kaminami
    Kaimen-Maciel, Damacio Ramon
    Lopes, Josiane
    de Carvalho Jennings Pereira, Wildea Lice
    Andrade, Renato Marques
    Pelegrino, Larissa Muliterno
    Vissoci Reiche, Edna Maria
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1832 - 1832
  • [48] Effect of ofatumumab treatment on disability progression independent of relapse activity in patients with relapsing multiple sclerosis
    Kappos, L.
    Montalban, X.
    Cohen, J. A.
    Comi, G.
    Coyle, P. K.
    Li, B.
    Sfikas, N.
    Willi, R.
    Haring, D. A.
    Merschhemke, M.
    Hauser, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 47 - 47
  • [49] COST ANALYSIS OF GLATIRAMER ACETATE VERSUS FINGOLIMOD FOR THE TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Sanchez-de la Rosa, R.
    Sabater, E.
    Casado, M. A.
    VALUE IN HEALTH, 2012, 15 (07) : A551 - A551
  • [50] COST-EFFECTIVENESS OF DACLIZUMAB VERSUS FINGOLIMOD IN THE TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN NORWAY
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Haines, P.
    Liu, Y.
    Bjornstad, B. M.
    Haukaas, F. S.
    VALUE IN HEALTH, 2016, 19 (07) : A433 - A433
12345